Figures
Abstract
Objective
In a previous study, we observed that associations between APOE rs439401 and metabolic traits were moderated by chronic stress. Thus, in a population of stressed and non-stressed Danish men, we examined whether associations between APOE rs439401 and a panel of metabolic quantitative traits, all metabolic traits which may lead to T2D and CVD were moderated by psychological stress.
Methods
Obese young men (n = 475, BMI≥31.0 kg/m2) and a randomly selected control group (n = 709) identified from a population of 141,800 men were re-examined in two surveys (S-46: mean age 46, S-49: mean age 49 years) where anthropometric and biochemical measures were available. Psychological stress factors were assessed by a self-administered 7-item questionnaire. Each item had the possible response categories “yes” and “no” and assessed familial problems and conflicts. Summing positive responses constituted a stress item score, which was then dichotomized into stressed and non-stressed. Logistic regression analysis, applying a recessive genetic model, was used to assess odds ratios (OR) of the associations between APOE rs439401 genotypes and adverse levels of metabolic traits.
Results
The APOE rs439401 TT-genotype associated positively with BMI (OR = 1.09 [1.01; 1.17]), waist circumference (OR = 1.09 [1.02; 1.17]) in stressed men at S-46. Positive associations were observed for fasting plasma glucose (OR = 1.42 [1.07; 1.87]), serum triglycerides (OR = 1.41 [1.05; 1.91]) and with fasting plasma insulin (OR = 1.48 [1.05; 2.08]) in stressed men at S-49. Rs439401 TT-genotype also associated positively with surrogate measures of insulin resistance (HOMA-IR; OR = 1.21 [1.03; 1.41]) and inversely with insulin sensitivity (Stumvoll index; OR = 0.90 [0.82; 0.99], BIGTT-SI; OR = 0.60 [0.43; 0.85]) in stressed men. No significant associations were observed in non-stressed men, albeit the estimates showed similar but weaker trends as in stressed men.
Citation: Iqbal Kring SI, Barefoot J, Brummett BH, Boyle SH, Siegler IC, Toubro S, et al. (2011) Associations between APOE Variants and Metabolic Traits and the Impact of Psychological Stress. PLoS ONE 6(1): e15745. https://doi.org/10.1371/journal.pone.0015745
Editor: Takeo Yoshikawa, Rikagaku Kenkyūsho Brain Science Institute, Japan
Received: September 17, 2010; Accepted: November 27, 2010; Published: January 19, 2011
Copyright: © 2011 Kring et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Funding: This study was financially supported by Center for Pharmacogenomics at the University of Copenhagen, Denmark, and by NHLBI grant P01HL36587 and the Behavioral Medicine Research Center, Duke University Medical Center, Durham, NC, USA. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
Competing interests: The authors have declared that no competing interests exist.
Introduction
Obesity is associated with a number of deleterious consequences, such as development of metabolic diseases and type 2 diabetes (T2D), which may lead to cardiovascular disease (CVD) [1]–[3]. Abdominal obesity, insulin resistance and an adverse plasma lipid profile make up a cluster of metabolic traits that has been associated with increased CVD risk [3], [4]. APOE (chromosome 19q12-13.2) is known to have a key role in determining inter-individual differences in lipid metabolism [5], [6], and APOE gene variants may alter glucose metabolism [6], [7] moderated by obesity [8]–[10]. APOE gene variants may thus, be important in association studies of metabolic traits.
In a previous study, associations between APOE rs439401 TT-genotype and an adverse metabolic profile (increased waist circumference, triglycerides and insulin; decreased HDL-cholesterol) were observed in a sample of chronically stressed U.S. caregivers [11]. In order to elucidate the relationship between the APOE polymorphism and stress-related vulnerability to develop a detrimental metabolic profile further research will be required to replicate our previously reported associations. Thus, in the present study, we examined APOE rs769450, rs405509 and rs439401 in relation to obesity and related metabolic quantitative traits in a group of middle-aged Danish men according to their perceived stress levels.
Material and Methods
Study population
Among 362,200 Caucasian men examined at the mean age of 20 years at the draft boards in Copenhagen and its surroundings during 1943–77, a randomly selected group of one in every hundred men (n = 3,601) and all obese men (n = 1,930) were identified. Obesity was defined as 35% overweight relative to a local standard in use at the time, and this corresponds to a BMI≥31.0 kg/m2, which proved to be above the 99th percentile. All obese and half of the random sample, still living in the region, were invited to a follow-up survey in 1992–94 at the mean age of 46 years (survey S-46) and in 1998–2000 at the mean age of 49 years (survey S-49). The criteria for invitation to the follow-up surveys and the participation have been described previously [12]–[14], and the number of participants shows the expected attrition over time (Table 1). Phenotypic assessments were carried out at all surveys, though most extensively at survey S-49. DNA was sampled from blood sample buffy coats at S-46. In total, 1,184 (475 obese and 709 randomly selected) participants were genotyped, indicating that the randomly selected group represent 141,800 men originally identified at the draft board examination. Among these 385 (143 obese and 242 randomly selected) had been assessed in S-49.
Ethics Statement
The Danish Data Protection Agency and the Ethical Committees of Copenhagen and Frederiksberg municipalities approved the study, which was in accordance with the Helsinki Declaration II. All participants signed written consent before participating.
Molecular genetic analyses
Genotyping of the APOE tagging SNPs (rs769450, rs405509, rs439401) were performed using Taqman allelic discrimination (KBioScience, Herts, UK). Genotyping was successful for rs769450, rs405509 and rs439401 on 1,184 participants. All genotype groups obeyed Hardy-Weinberg equilibrium (P>0.05; Table 1).
Phenotypic measurements
Waist circumference (cm) was measured according to the WHO recommendations to the nearest 0.5 cm with the subjects standing, using a nonexpendable linen tape measure [15]. Participants in S-46 had non-fasting glucose and lipid levels determined on fresh plasma samples. In the S-49 cohort, an oral glucose tolerance test (OGTT) was conducted, except in individuals with diagnosed and therefore likely treated diabetes (n = 10) [12]. We also computed HOMA-IR and derived indices of insulin sensitivity according to Stumvoll [16] and the recently recommended BIGTT index [17]. Insulin sensitivity and acute insulin response were assessed by the recently recommended BIGTT indices (BIGTT-SI and BIGTT-AIR, respectively) on the basis of measurements of plasma glucose and insulin at the time points 0, 30 and 120 minutes during the OGTT [17]. Details on data collections and measurement of anthropometric and biochemical variables have been described elsewhere [12], [18], [19].
Psychological stress
Stress factors were assessed by a self-administered 7-item questionnaire (Table 2) checked with the participant by trained staff, and by various laboratory tests. Each item of the questionnaire that had the possible response categories “yes” and “no” assessed familial problems and conflicts (items given in table 2). Summing positive responses constituted a stress item score (range: 0–7), which was then grouped into two categories: 0 (n = 393) and ≥1 (n = 791) items positive in the present study. The stress variable was validated in the entire cohort of Copenhagen City Heart Study and was highly correlated with vital exhaustion, a psychological measure characterized by fatigue and depressive symptoms, that in a previous study has been associated with ischemic heart disease and all-cause mortality [20].
Statistics
A likelihood ratio test for an additive, a dominant and a recessive effect of the genotyped variants determined that a recessive genetic model was chosen for rs439401, rs405509 and rs769450 (wild type and heterozygous genotype versus homozygous genotype).
In order to properly take into account the sampling design, the two groups of obese and controls have been analysed together for the logistic regression analyses, but separately for each follow-up survey S-46 and S-49. The massive enrichment of the right tail of the BMI distribution implies that the data cannot be analysed with BMI or BMI-associated outcomes as response variables in common regression models. Also, using a dichotomized case-control approach would waste considerable statistical efficiency otherwise gained by using the quantitative phenotypes. Hence, to take advantage of the greater statistical power and much wider coverage of the phenotypes, we reversed the statistical models for the associations and examined the probability of carrying the particular risk-allele genotype for a given level of the phenotypes. This can be done without distributional assumptions about the phenotypes. Thus, logistic regression analysis was used to assess the ORs of the genotype (response variable) in relation to the phenotypes (covariates) in the combined obese and randomly selected control groups. There were no indications of multicollinearity among the phenotypes. The purpose of the regression analyses was to estimate and test the specific hypotheses while controlling for relevant covariates. All analyses were stratified according to stress levels (stressed/non-stressed) and adjusted for age as a continuous metabolic variable. P-values<0.05 were considered statistically significant. Analyses were performed using SAS statistical procedures (version 9.1; SAS Institute Inc, Cary, NC).
Results
Descriptive characteristics
In table 3 mean values of age, and metabolic traits are given for the pooled group of participants, and also separately for stressed and non-stressed participants for each survey. Only age at S-46 was significantly lower in stressed participants compared with non-stressed participants (p = 0.001).
Regression analyses for metabolic traits
Results from logistic regression analyses for metabolic traits are given as OR with 95% confidence intervals. Significant associations between participants homozygous for the minor T-allele for rs439401 were observed in stressed individuals for BMI and waist circumference in S-46 and fasting plasma glucose, insulin, triglycerides in S-49 (Table 4).
In S-46, a two-unit increase in BMI (kg/m2) was positively associated with increased odds of 9% for being homozygous for the minor T-allele in stressed individuals (OR = 1.09 [1.01; 1.17]; Table 4). Likewise, each five cm increment in waist circumference was positively associated with increased odds of 9% for being homozygous for the minor T-allele in stressed individuals (OR = 1.09 [1.02; 1.17]).
In S-49, one unit increase of glucose and triglycerides (mmol/L) was positively associated with increased odds of 42% and 41%, respectively, for being homozygous for the minor T-allele in stressed individuals (glucose: OR = 1.42 [1.07; 1.87]; triglycerides: OR = 1.41 [1.05; 1.91]. Further, one unit increase of insulin (50 pmol/L) was positively associated with increased odds of 48% for being homozygous for the minor T-allele in stressed individuals in S-49 (insulin: OR = 1.48 [1.05; 2.08]). HDL-cholesterol and systolic blood pressure were not significantly associated with rs439401 in either survey. No significant associations were observed among non-stressed individuals. No significant associations were observed for rs769450 or rs405509.
Regression analyses for derived indices
Derived indices for insulin resistance and insulin sensitivity revealed significant results, in S-49. In stressed individuals, one unit increase in HOMA index for insulin resistance was positively associated with increased odds of 21% for being homozygous for the minor T-allele (OR = 1.21 [1.03; 1.41]). One unit increase in Stumvoll index for insulin sensitivity was inversely associated with decreased odds of 10% for being homozygous for the minor T-allele in stressed individuals (OR = 0.90 [0.82; 0.99]). Similar estimates were observed when insulin sensitivity was assessed as Matsuda index, albeit borderline significant, only. These results were strongly confirmed when using the OGTT-derived measure for insulin sensitivity (BIGTT-SI), where one unit increase in BIGTT-SI was inversely associated with decreased odds of 40% for being homozygous for the minor risk T-allele in stressed individuals (OR = 0.60 [0.43; 0.85]). No notable associations were observed among non-stressed individuals.
Discussion
The present study of Danish men confirmed associations of APOE rs439401 with quantitative metabolic traits [11], which were also observed in a recent European genome-wide association study of blood lipid levels [21]. The rs439401 TT-genotype was positively associated with obesity, assessed as BMI and waist circumference at survey S-46. Although estimates were almost similar, the results from S-49 did not reach statistical significance, with regard to BMI and waist circumference. Positive associations were also observed for the rs439401 TT-genotype in relation to fasting plasma glucose, insulin and triglyceride levels at survey S-49. All associations were, however, only present in stressed Danish men compared with non-stressed men. Further, associations of the TT genotype with surrogate measures of whole body insulin resistance and insulin sensitivity were observed only in stressed participants.
The present results are in agreement with our first study of APOE rs439401 and metabolic traits of T2D and CVD [11]. In our previous study, the rs439401 TT-genotype was associated with elevated waist circumference, insulin, and triglyceride levels and decreased HDL-cholesterol level among chronic stressed men and women compared with carriers of the rs439401 C-allele. It is not clear in the present data of stressed Danish men why associations of the TT-genotype with BMI, glucose and HOMA-IR were not found in stressed U.S. caregivers.
One possible contributor to the different patterns of associations is the nature of the psychosocial stressors in the two study populations. Being the primary caregiver for a relative with Alzheimer's disease or other major dementia is a life stressor that is chronic, unremitting and pervasive for the caregiver [22]–[24]. In contrast, while the stressors used to define stress versus no stress in the Danish sample have effects on health, it is likely that they are less severe and pervasive in daily life than being the caregiver. It is also possible that, in addition to the metabolic consequences of obesity, it was only in men with high general psychosocial stress and the added particular stress imposed by being obese that the effects of rs439401 genotype were present. Overall, the present results in Danish men accomplish our goal of replication by showing a similar pattern of association between APOE rs439401 and metabolic traits that is moderated by stress.
The strengths of the present population-based study of Danish men include the repetitive detailed assessment of anthropometric and physiological variables at mean ages 46 and 49 years for the same individuals in different subsets of the cohort, which makes the present study population unique and appropriate for investigating the impact of gene variants on body weight and related metabolic traits. Several limitations, however, need to be acknowledged. The S-46 includes a much less demanding examination program and the participants cover a much broader part of the original cohort, whereas the S-49 was a very intensive and demanding examination program, including for example ventilated hood measurements of metabolic rates and VO2 max measurement, for which we needed to select participants capable of completing such program [12]. This selection process may lead to differences in the phenotypic measurements.
Although the hypotheses of our study were directly derived form the previously published study of chronically stressed American care-givers [11], the finding may still be considered exploratory and therefore need further replication. Population stratification may occur due to systematic admixture of ancestry and lead to spurious associations [25]. However, population stratification is unlikely to explain the obtained results due to the homogenous study population of Danish Caucasian men, in which the examined genotype distributions complied with Hardy-Weinberg equilibrium. The present sample size may seem small for a genetic association study, but was able to confirm the association between rs439401 TT genotype and an adverse profile of metabolic traits only in stressed persons found in our previous study [11]. Keeping the phenotypes as quantitative variables in the analyses, however, the efficiency is considerably higher as reflected in the fairly narrow confidence intervals, which means that we thereby have narrowed down the likely true ORs that could have given rise to the observed ORs. The metabolic traits associated with obesity may be inter-correlated to various extents, but according to a recent twin study [26], there is little common underlying genetic or shared environmental etiology behind these correlations, which we think justifies the separate analysis of each of the traits as we have conducted.
In conclusion, the results from the present study confirmed that APOE rs439401 associated with a panel of metabolic traits, moderated by psychological stress. The results were a replication of our previous study of chronic stressed U.S. caregivers in whom a similar adverse metabolic profile was observed. If confirmed in further research, particularly in a prospective study with sufficient incidence of T2D and CVD over time, the findings in these two studies suggest that the APOE rs439401 TT-genotype might be used to identify persons at high risk of developing T2D and/or CVD who might be targeted for preventive interventions.
Author Contributions
Conceived and designed the experiments: SIIK JCB RBW TIAS. Performed the experiments: SIIK JB. Analyzed the data: SIIK. Contributed reagents/materials/analysis tools: SIIK JB RBW TIAS. Wrote the manuscript: SIIK. Contributed with helpful comments and suggestions: BHB SHB ICS ST. Supervised the genetic aspects of the study: TH OP. Supervised physiological aspects of the study: AA. Supervised the study: RBW TIAS.
References
- 1. Kahn SE (2003) The relative contributions of insulin resistance and beta-cell dysfunction to the pathophysiology of Type 2 diabetes. Diabetologia 46/1: 3–19.
- 2. Martyn JA, Kaneki M, Yasuhara S (2008) Obesity-induced insulin resistance and hyperglycemia: etiologic factors and molecular mechanisms. Anesthesiology 109/1: 137–148.
- 3. Despres JP (2001) Health consequences of visceral obesity. Ann Med 33/8: 534–541.
- 4. Kahn SE, Hull RL, Utzschneider KM (2006) Mechanisms linking obesity to insulin resistance and type 2 diabetes. Nature 444/7121: 840–846.
- 5. Song Y, Stampfer MJ, Liu S (2004) Meta-analysis: apolipoprotein E genotypes and risk for coronary heart disease. Ann Intern Med 141/2: 137–147.
- 6. Breslow JL (2000) Genetics of lipoprotein abnormalities associated with coronary artery disease susceptibility. Annu Rev Genet 34: 233–254.
- 7. Eichner JE, Dunn ST, Perveen G, Thompson DM, Stewart KE, et al. (2002) Apolipoprotein E Polymorphism and Cardiovascular Disease: A HuGE Review. Am J Epidemiol 155/6: 487–495.
- 8. Fumeron F, Rigaud D, Bertiere MC, Bardon S, Dely C, et al. (1988) Association of apolipoprotein epsilon 4 allele with hypertriglyceridemia in obesity. Clin Genet 34/4: 258–264.
- 9. Elosua R, Demissie S, Cupples LA, Meigs JB, Wilson PW, et al. (2003) Obesity modulates the association among APOE genotype, insulin, and glucose in men. Obes Res 11/12: 1502–1508.
- 10. Jemaa R, Elasmi M, Naouali C, Feki M, Kallel A, et al. (2006) Apolipoprotein E polymorphism in the Tunisian population: frequency and effect on lipid parameters. Clin Biochem 39/8: 816–820.
- 11. Kring SI, Brummett BH, Barefoot J, Garrett ME, Ashley-Koch AE, et al. (2010) Impact of psychological stress on the associations between apolipoprotein E variants and metabolic traits: findings in an American sample of caregivers and controls. Psychosom Med 72/5: 427–433.
- 12. Black E, Holst C, Astrup A, Toubro S, Echwald S, et al. (2005) Long-term influences of body-weight changes, independent of the attained weight, on risk of impaired glucose tolerance and Type 2 diabetes. Diabet Med 22/9: 1199–1205.
- 13. Kring SII, Larsen LH, Holst C, Toubro S, Hansen T, et al. (2008) Genotype-phenotype associations in obesity dependent on definition of the obesity phenotype. Obesity Facts 1: 138–145.
- 14. Sonne-Holm S, Sørensen TIA, Jensen G, Schnohr P (1989) Independent effects of weight change and attained body weight on prevalence of arterial hypertension in obese and non-obese men. BMJ 299/6702: 767–770.
- 15.
World Health Organization (2003) Physical status: The Use and Interpretation of Anthropometry Report of a WHO Expert Committee. Geneva, Switzerland: WHO.
- 16. Stumvoll M, Mitrakou A, Pimenta W, Jenssen T, Yki-Jarvinen H, et al. (2000) Use of the oral glucose tolerance test to assess insulin release and insulin sensitivity. Diabetes Care 23/3: 295–301.
- 17. Hansen T, Drivsholm T, Urhammer SA, Palacios RT, Volund A, et al. (2007) The BIGTT test: a novel test for simultaneous measurement of pancreatic beta-cell function, insulin sensitivity, and glucose tolerance. Diabetes Care 30/2: 257–262.
- 18. Schnohr P, Jensen G, Lange P, Scharling H, Appleyard M (2001) The Copenhagen City Heart Study. Tables with data from the third examination 1991–1994. Journal of the European Society of Cardiology 3,: Supplement H
- 19. Buemann B, Sørensen TIA, Pedersen O, Black E, Holst C, et al. (2005) Lower-body fat mass as an independent marker of insulin sensitivity - the role of adiponectin. Int J Obes Relat Metab Disord 29/6: 624–631.
- 20. Prescott E, Holst C, Gronbaek M, Schnohr P, Jensen G, et al. (2003) Vital exhaustion as a risk factor for ischaemic heart disease and all-cause mortality in a community sample. A prospective study of 4084 men and 5479 women in the Copenhagen City Heart Study. Int J Epidemiol 32/6: 990–997.
- 21. Aulchenko YS, Ripatti S, Lindqvist I, Boomsma D, Heid IM, et al. (2009) Loci influencing lipid levels and coronary heart disease risk in 16 European population cohorts. Nat Genet 41/1: 47–55.
- 22. Brummett BH, Babyak MA, Siegler IC, Vitaliano PP, Ballard EL, et al. (2006) Associations among perceptions of social support, negative affect, and quality of sleep in caregivers and noncaregivers. Health Psychol 25/2: 220–225.
- 23. Brummett BH, Krystal AD, Ashley-Koch A, Kuhn CM, Zuchner S, et al. (2007) Sleep quality varies as a function of 5-HTTLPR genotype and stress. Psychosom Med 69/7: 621–624.
- 24. Brummett BH, Krystal AD, Siegler IC, Kuhn C, Surwit RS, et al. (2007) Associations of a regulatory polymorphism of monoamine oxidase-A gene promoter (MAOA-uVNTR) with symptoms of depression and sleep quality. Psychosom Med 69/5: 396–401.
- 25. Cordell HJ, Clayton DG (2005) Genetic association studies. Lancet 366/9491: 1121–1131.
- 26. Benyamin B, Sørensen TIA, Schousboe K, Fenger M, Visscher PM, et al. (2007) Are there common genetic and environmental factors behind the endophenotypes associated with the metabolic syndrome? Diabetologia 50/9: 1880–1888.